Johnson Investment Counsel’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.7M Sell
33,088
-1,927
-6% -$1.97M 0.29% 81
2026
Q1
$32.2M Sell
35,015
-474
-1% -$481K 0.26% 91
2025
Q4
$38.1M Sell
35,489
-42
-0.1% -$40.2K 0.31% 80
2025
Q3
$27.1M Buy
35,531
+753
+2% +$560K 0.23% 90
2025
Q2
$27.1M Buy
34,778
+481
+1% +$374K 0.24% 87
2025
Q1
$28.3M Sell
34,297
-300
-0.9% -$250K 0.27% 82
2024
Q4
$26.7M Buy
34,597
+628
+2% +$520K 0.26% 82
2024
Q3
$30.1M Buy
33,969
+122
+0.4% +$110K 0.3% 80
2024
Q2
$30.6M Sell
33,847
-901
-3% -$721K 0.32% 77
2024
Q1
$27M Buy
34,748
+9,588
+38% +$6.82M 0.29% 78
2023
Q4
$14.7M Buy
25,160
+284
+1% +$166K 0.17% 91
2023
Q3
$13.4M Sell
24,876
-297
-1% -$153K 0.17% 91
2023
Q2
$11.8M Sell
25,173
-418
-2% -$175K 0.15% 95
2023
Q1
$8.79M Sell
25,591
-385
-1% -$130K 0.12% 108
2022
Q4
$9.5M Buy
25,976
+1,300
+5% +$461K 0.13% 106
2022
Q3
$7.98M Buy
24,676
+99
+0.4% +$31.4K 0.12% 110
2022
Q2
$7.97M Buy
24,577
+791
+3% +$237K 0.11% 114
2022
Q1
$6.81M Sell
23,786
-570
-2% -$147K 0.08% 129
2021
Q4
$6.73M Buy
24,356
+76
+0.3% +$19.3K 0.08% 129
2021
Q3
$5.61M Sell
24,280
-319
-1% -$78.7K 0.08% 139
2021
Q2
$5.65M Sell
24,599
-609
-2% -$122K 0.08% 130
2021
Q1
$4.71M Sell
25,208
-383
-1% -$74.9K 0.07% 138
2020
Q4
$4.32M Sell
25,591
-1,210
-5% -$181K 0.07% 134
2020
Q3
$3.97M Buy
26,801
+220
+0.8% +$34K 0.07% 132
2020
Q2
$4.36M Sell
26,581
-2,924
-10% -$449K 0.09% 124
2020
Q1
$4.09M Sell
29,505
-236
-0.8% -$32.4K 0.09% 119
2019
Q4
$3.91M Sell
29,741
-1,937
-6% -$225K 0.07% 144
2019
Q3
$3.54M Sell
31,678
-587
-2% -$65.4K 0.07% 146
2019
Q2
$3.57M Sell
32,265
-339
-1% -$39.9K 0.07% 149
2019
Q1
$4.23M Sell
32,604
-1,973
-6% -$240K 0.09% 137
2018
Q4
$4M Buy
34,577
+3,792
+12% +$424K 0.1% 136
2018
Q3
$3.3M Sell
30,785
-1,059
-3% -$106K 0.07% 156
2018
Q2
$2.72M Sell
31,844
-583
-2% -$47.9K 0.07% 165
2018
Q1
$2.51M Sell
32,427
-1,318
-4% -$106K 0.06% 165
2017
Q4
$2.85M Sell
33,745
-1,583
-4% -$135K 0.07% 155
2017
Q3
$3.02M Sell
35,328
-926
-3% -$75.9K 0.08% 150
2017
Q2
$2.98M Buy
36,254
+4,106
+13% +$335K 0.08% 142
2017
Q1
$2.7M Sell
32,148
-361
-1% -$28.9K 0.08% 145
2016
Q4
$2.39M Buy
32,509
+1,644
+5% +$122K 0.07% 153
2016
Q3
$2.48M Buy
30,865
+211
+0.7% +$16.9K 0.08% 149
2016
Q2
$2.41M Sell
30,654
-324
-1% -$24.4K 0.08% 156
2016
Q1
$2.23M Buy
30,978
+2,524
+9% +$191K 0.08% 150
2015
Q4
$2.4M Sell
28,454
-2,453
-8% -$204K 0.08% 146
2015
Q3
$2.59M Buy
30,907
+1,528
+5% +$129K 0.09% 139
2015
Q2
$2.45M Buy
29,379
+93
+0.3% +$7.09K 0.08% 138
2015
Q1
$2.13M Sell
29,286
-515
-2% -$36.7K 0.07% 156
2014
Q4
$2.06M Sell
29,801
-326
-1% -$22K 0.07% 155
2014
Q3
$1.95M Buy
30,127
+183
+0.6% +$11.6K 0.07% 148
2014
Q2
$1.86M Buy
29,944
+657
+2% +$39.2K 0.07% 137
2014
Q1
$1.72M Sell
29,287
-3,909
-12% -$218K 0.06% 144
2013
Q4
$1.69M Sell
33,196
-8
-0% -$401 0.06% 148
2013
Q3
$1.67M Buy
33,204
+3,719
+13% +$195K 0.07% 142
2013
Q2
$1.45M Buy
+29,485
New +$1.6M 0.06% 149

Other funds holding LLY

Johnson Investment Counsel's LLY Position: Q2 2026 in Review

Johnson Investment Counsel reduced its Eli Lilly (LLY) stake by 5.5% in Q2 2026, selling an estimated $1.97M and leaving 33,088 shares worth $39.7M. The position accounts for 0.29% of the portfolio, ranked #81.

Johnson Investment Counsel first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 1,592 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Johnson Investment Counsel held 33,088 shares of Eli Lilly worth $39.7M as of Q2 2026.
  • Johnson Investment Counsel sold 1,927 Eli Lilly shares in Q2 2026, an estimated $1.97M.
  • Eli Lilly made up 0.29% of Johnson Investment Counsel's portfolio in Q2 2026, its #81 holding.
  • Johnson Investment Counsel first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 1,592 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.